MB-501

N/A

Report date: 2025/02/14 11:38:46

Base Information

Drug NameMB-501
Drug Alias NameTransCon IL-2 β/γMB501MB-501
ClassificationOther
Mechanisms of ActionInterleukin-2 receptor beta chain modulatorsInterleukin-2 receptor subunit gamma modulators
TargetsInterleukin-2 receptor beta chainInterleukin-2 receptor subunit gamma
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAscendis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscendis Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A